Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents: A protocol for systematic review and meta-analysis

INTRODUCTION: Existing evidence on the difference in the incidence of tumor lysis syndrome (TLS) in Chronic Lymphocytic Leukemia (CLL) patients receiving novel therapies versus patients receiving conventional therapies is limited and inconclusive. The aims of this planned systematic review and meta-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassem, Nancy, Ghazy, Ahmed A., Abu-Tineh, Mohammad, Omar, Nabil E., Nashwan, Abdulqadir J., Chandra, Prem, Ghasoub, Rola, AbuTabar, Osama S., Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748317/
https://www.ncbi.nlm.nih.gov/pubmed/33371096
http://dx.doi.org/10.1097/MD.0000000000023632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748317/
https://www.ncbi.nlm.nih.gov/pubmed/33371096
http://dx.doi.org/10.1097/MD.0000000000023632

Ejemplares similares